Home - Products - Others - Other Targets - Capitatin 3-O-β-D-glucopyranosyl-7-O-α-L-rhamnopyranoside

Capitatin 3-O-β-D-glucopyranosyl-7-O-α-L-rhamnopyranoside

CAS No. ———

Capitatin 3-O-β-D-glucopyranosyl-7-O-α-L-rhamnopyranoside( ——— )

Catalog No. M38448 CAS No. ———

Capitatin 3-O-β-D-glucopyranosyl-7-O-α-L-rhamnopyranoside

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Capitatin 3-O-β-D-glucopyranosyl-7-O-α-L-rhamnopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Capitatin 3-O-β-D-glucopyranosyl-7-O-α-L-rhamnopyranoside
  • Description
    Capitatin 3-O-β-D-glucopyranosyl-7-O-α-L-rhamnopyranoside
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • MR837

    ZINC30303842 is a NSD2-PWWP1 antagonist.

  • V9302

    V-9302 (V9302) is a competitive antagonist of transmembrane glutamine flux that selectively and potently targets the amino acid transporter ASCT2 (IC50: 9.6 uM).

  • KL-11743

    KL-11743 specifically blocks glucose metabolism, triggering an acute collapse in NADH pools and a striking accumulation of aspartate, indicating a dramatic shift toward oxidative phosphorylation in the mitochondria.